CAR-T cells with a TNFRSF9 domain showed powerful and specific cytotoxicity for B-ALL with more production of IL12 compared to CAR-T cells without a TNFRSF9 domain, indicating that an additional signaling domain is necessary for enhanced activity of CAR-T cells [18]. The gene discussed is TNFRSF9; the disease is acute lymphoblastic leukemia.